
Wall Street chases AI hype… but the $100B+ pet healthcare boom is happening in your neighborhood vet clinic.
$ZOMDF (Zomedica) sells specialized diagnostics + shockwave therapy to U.S. animal clinics.
The moat? High-margin recurring consumables delivering 68% gross margins.
Record Q1 revenue +35% YoY. 17 straight quarters of growth. $47M+ cash. Trading at just $0.10.
Real edge in a fragmented market or just another penny stock?
DYOR
#ZOMDF #PetHealth #Microcap #Stocks
English














